Company Overview

Business Description

Sector
Health Care
Industry
Life Sciences Tools & Services
Headquarters
United States of America US
Employees
2 900
IPO date
Feb 2, 1995

Azenta Inc. sells tools and services that help life science customers store, track, move, and analyze biological samples. Its core products include automated sample storage systems, lab automation equipment, cryogenic storage, and the software and consumables needed to manage those samples safely. It also offers genomic and sequencing services for research and clinical work.

Its main customers are pharmaceutical and biotech companies, hospitals, academic research labs, and other organizations that handle valuable samples such as blood, tissue, and DNA. Azenta makes money by selling equipment, consumables, service contracts, storage and logistics services, and testing or sequencing services. That mix gives it both one-time product sales and recurring service revenue.

What makes Azenta different is that it sits in the infrastructure layer of life sciences. Instead of making drugs or running experiments itself, it helps customers protect sample quality, keep large collections organized, and get material to the right place at the right time. That makes it a behind-the-scenes partner for labs that depend on reliable sample handling and data traceability.

Azenta Inc Investor Relations

Address
200 Summit Drive, 6Th Floor
Burlington, Massachusetts
United States of America

Business Segments

Sample management

This business designs and sells automated storage systems, sample tubes, consumables, and related software used to store, track, and retrieve biological samples in labs and biobanks.

Customers

Biotech and pharmaceutical companies, research labs, hospitals, universities, and sample repository operators.

Revenue Model

It earns money from selling equipment, consumables, software, service contracts, and support for installed systems.

Multiomic services

This business provides genomics and other molecular testing services that help customers analyze biological samples for research and drug development.

Customers

Drug developers, life science researchers, and other organizations that need outsourced sample analysis and data generation.

Revenue Model

It earns money by charging fees for testing, analysis, and related project services.

1 / 2

Management

Mr. Jason W. Joseph J.D.

Senior VP, General Counsel & Corporate Secretary

Biography unavailable

Mr. Lawrence Y. Lin

Executive VP & CFO

Biography unavailable

Mr. Michael Paulo

VP and Chief Information & Digital Officer

Biography unavailable

Ms. Yvonne Perron

Vice President of Financial Planning & Analysis and Investor Relations

Biography unavailable

Mr. John E. O'Brien

Senior Vice President of Corporate Development

Biography unavailable

Ms. Olga Pirogova

Senior VP & Chief HR Officer

Biography unavailable

Mr. J. Robert Woodward

Senior Vice President of Global Quality & Regulatory

Biography unavailable

Dr. Ginger Zhou Ph.D.

Senior VP and GM of the Genewiz Multiomics & Synthesis Solutions

Biography unavailable

Mr. David Wang

Senior VP & GM of Sample Management Solutions

Biography unavailable

Mr. Herman Cueto

Employee Advisor

Biography unavailable

1 / 10